Inagaki N, Miura T, Nakajima T, Yoshida K, Nagai H, Koda A
Department of Pharmacology, Gifu Pharmaceutical University, Japan.
J Pharmacobiodyn. 1992 Oct;15(10):581-7. doi: 10.1248/bpb1978.15.581.
Glucocorticoids inhibit IgE antibody-mediated passive cutaneous anaphylaxis (PCA) and chemical mediator-induced cutaneous reactions elicited in the mouse ear. In the present study, we investigated the effect of actinomycin D, a protein synthesis inhibitor, on dexamethasone-caused inhibition of PCA and histamine-induced cutaneous reaction in the mouse ear. Tyrosine aminotransferase (TAT) activity in the liver, which was estimated as an index for protein synthesis, significantly increased by the administration of hydrocortisone, prednisolone and dexamethasone. Significant increase in TAT activity was observed from 2 h after glucocorticoid administration and peaked at 4 h, and declined gradually thereafter. Cycloheximide even at high doses of 100 and 300 mg/kg failed to affect the increase in TAT activity by dexamethasone. On the contrary, actinomycin D at doses of 1 and 10 mg/kg abrogated the TAT activity increase by dexamethasone almost completely. Treatment with 1 mg/kg of actinomycin D, however, failed to affect the inhibition of PCA and histamine-induced cutaneous reaction by dexamethasone. These results suggest that glucocorticoids exhibit their inhibitory action of PCA and chemical mediator-induced cutaneous reactions in mice through a mechanism resistant to actinomycin D treatment.
糖皮质激素可抑制IgE抗体介导的被动皮肤过敏反应(PCA)以及化学介质诱导的小鼠耳部皮肤反应。在本研究中,我们调查了蛋白质合成抑制剂放线菌素D对小鼠耳部地塞米松所致PCA抑制作用以及组胺诱导的皮肤反应的影响。作为蛋白质合成指标评估的肝脏中酪氨酸转氨酶(TAT)活性,在给予氢化可的松、泼尼松龙和地塞米松后显著增加。糖皮质激素给药后2小时观察到TAT活性显著增加,并在4小时达到峰值,此后逐渐下降。即使是高剂量100和300mg/kg的环己酰亚胺也未能影响地塞米松引起的TAT活性增加。相反,1和10mg/kg剂量的放线菌素D几乎完全消除了地塞米松引起的TAT活性增加。然而,用1mg/kg放线菌素D处理未能影响地塞米松对PCA和组胺诱导的皮肤反应的抑制作用。这些结果表明,糖皮质激素通过一种对放线菌素D处理有抗性的机制,对小鼠的PCA和化学介质诱导的皮肤反应发挥其抑制作用。